ArticleEuropean urology2019

Re: Effect of Adding Docetaxel to Androgen-Deprivation Therapy in Patients with High-risk Prostate Cancer with Rising Prostate-specific Antigen Levels After Primary Local Therapy A Randomized Clinical Trial.

Alexander Kretschmer et al.PubMed ↗Publisher ↗

No numbers read from the abstract.